Ultragenyx Pharmaceutical Inc.
Recent Filings
All 1,000 filings →| Form | Description | Date |
|---|---|---|
| ARS | ANNUAL REPORT TO SECURITY HOLDERS | Mar 27, 2026 |
| DEFA14A | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | Mar 27, 2026 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | Mar 27, 2026 |
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| 8-K | 8-K | Mar 12, 2026 |
| 4 | 4 | Mar 10, 2026 |
| 144 | — | Mar 10, 2026 |
| 144 | — | Mar 6, 2026 |
| 4 | 4 | Mar 3, 2026 |
| 4 | 4 | Mar 3, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Huizenga Theodore Alan | SVP, Chief Accounting Officer | Sale | 85 @ $34.38 | 50,450 | Dec 29, 2025 |
| Horn Howard | Chief Financial Officer | Sale | 3,081 @ $36.38 | 95,146 | Dec 10, 2025 |
| Horn Howard | Chief Financial Officer | Sale | 7,942 @ $31.51 | 98,227 | Oct 13, 2025 |
| Huizenga Theodore Alan | SVP, Chief Accounting Officer | Sale | 64 @ $29.17 | 50,242 | Sep 18, 2025 |
| Parschauer Karah Herdman | EVP and Chief Legal Officer | Sale | 2,450 @ $31.17 | 73,271 | Sep 12, 2025 |
| Huizenga Theodore Alan | SVP, Chief Accounting Officer | Sale | 84 @ $31.39 | 50,306 | Sep 5, 2025 |
| Sanders Corazon (Corsee) D. | — | Sale | 2,405 @ $37.39 | 15,344 | Jun 20, 2025 |
| SULIMAN SHEHNAAZ | — | Award / Grant | 5,740 | 25,940 | May 15, 2025 |
| WELCH DANIEL G | — | Award / Grant | 5,740 | 32,690 | May 15, 2025 |
| Sanders Corazon (Corsee) D. | — | Award / Grant | 5,740 | 17,749 | May 15, 2025 |